MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202511007811 A) filed by International Center For Genetic Engineering And Biotechnology Icgeb on January 30, 2025, for Dengue And Zikv Chimeric Vaccine Candidates.
Inventors include Kumar, Sanjeev; and Chandele, Anmol.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to DNA and/or protein based designed and engineered chimeric vaccine therapies for Dengue and Zika virus. Also provided are reagents and expression systems for manufacture of the DNA and/or protein based chimeric vaccine therapies. Fig. 1A-C
Disclaimer: Curated by HT Syndication.
